Selina Powell
More articles by Selina Powell
-
The US Food and Drug Administration has approved the use of MiSight to slow the progression of myopia in children aged between eight and 12
-
New research has shed light on the prevalence of short-sightedness in Japan
-
The Singapore National Eye Centre has opened a new myopia clinic with a focus on research as well as clinical care
-
A US experiment will involve children sleeping over in a lab before being periodically exposed to red and blue lights
-
Scientists are looking to recruit short-sighted children between the ages of six and 10 for a trial testing a new myopia treatment
-
Hong Kong scientists have reported promising results from a two-year randomised clinical trial involving 183 children in British Journal of Ophthalmology
-
Bright natural light may be effective in lessening the effects of lazy eye, according to new research
-
Dr Mark Bullimore tells OT that an optometrist’s smallest patients are often their most compliant wearers – and can reap long-term eye health benefits
-
A UK trial of 0.01% atropine to limit myopic progression in children could be an important step in addressing the increasing prevalence of short-sightedness internationally
-
The Queen’s University Belfast professor discusses a UK trial of 0.01% atropine for the management of myopia in children